2026-01-16 - Analysis Report
**Huntington Ingalls Industries Inc - HII Stock Report**
=====================================================

**Overview**
------------

Huntington Ingalls Industries Inc is a leading American aerospace and defense company.

**Return Rate Comparison**
-------------------------

### Cumulative Return Comparison

| Stock | Cumulative Return |
| --- | --- |
| HII | 97.43% |
| VOO | 92.89% |

Divergence: 4.54 (Current - 4.50), Relative divergence: 77.80%
Divergence indicates the degree of difference between the return rates of HII and VOO.

**Alpha, Beta Analysis**
------------------------

| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | -3.0% | 24.8% | -7.0% | 0.9 | 7.5B |
| 2017-2019 | 6.0% | 24.8% | -11.0% | 1.0 | 9.9B |
| 2018-2020 | -27.0% | 24.8% | -48.0% | 0.9 | 6.8B |
| 2019-2021 | 8.0% | 23.5% | -36.0% | 0.8 | 7.4B |
| 2020-2022 | -17.0% | 21.4% | -15.0% | 0.7 | 9.2B |
| 2021-2023 | 42.0% | 15.3% | 41.0% | 0.5 | 10.3B |
| 2022-2024 | -8.0% | 34.3% | -27.0% | 0.6 | 7.5B |
| 2023-2025 | 47.0% | 40.8% | -15.0% | 0.7 | 13.5B |

**Recent Stock Price Fluctuations**
--------------------------------

| Metric | Value |
| --- | --- |
| Close | $415.39 |
| Last-market | $420.00 |
| 5-day SMA | $398.15 |
| 20-day SMA | $358.89 |
| 60-day SMA | $326.27 |

**Analyzing RSI, PPO Index Indicators**
----------------------------------------

| Metric | Value |
| --- | --- |
| RSI | 76.71 |
| PPO | 1.50 |
| MRI | 0.70 |
| Recent relative divergence change | 24.60 (+) |
| 7-day Rank change | 0 (0) |
| 7-day Dynamic Expected Return change | 0.00 (0) |
| Expected Return (%) | -7.90% |

**Recent News & Significant Events**
------------------------------------

### Recent News Headlines


*   [Here's Why You Should Add HII Stock to Your Portfolio Right Now](Yahoo Finance)
*   [How is Huntington Ingalls Industries stock performance compared to other aerospace and defense stocks](MSN)
*   [Interesting HII Put And Call Options For September 18th](Nasdaq)
*   [HII to Release Fourth Quarter 2025 Financial Results and Host Earnings Conference Call on February 5](Quiver Quantitative)
*   [Huntington Ingalls Industries (NYSE:HII) Stock Price Expected to Rise, Citigroup Analyst Says](MarketBeat)
*   [4 Reasons to Buy Huntington Ingalls Industries Stock Like There's No Tomorrow](AOL.com)

### Analyst Opinions
-------------------------

Analyst Consensus:

*   Key: Buy
*   Mean (1=StrongBuy~5=Sell): 2.45 (~Buy)
*   Opinions: 10
*   Target Price (avg/high/low): $376.50 / $450.00 / $292.00

**Recent Earnings Analysis**
---------------------------

| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-10-30 | 3.69 | $3.19B |
| 2025-07-31 | 3.86 | $3.08B |
| 2025-05-01 | 3.79 | $2.73B |
| 2024-10-31 | 2.56 | $2.75B |
| 2025-10-30 | 2.56 | $2.75B |

**Financial Information**
-------------------------

### Revenue and Profitability


| Quarter | Revenue | Profit Margin |
| --- | --- | --- |
| 2025-09-30 | $3.19B | 12.34% |
| 2025-06-30 | $3.08B | 12.82% |
| 2025-03-31 | $2.73B | 14.41% |
| 2024-12-31 | $3.00B | 10.69% |
| 2024-09-30 | $2.75B | 11.71% |

### Capital and Profitability


| Quarter | Equity | ROE |
| --- | --- | --- |
| 2025-09-30 | $4.98B | 2.91% |
| 2025-06-30 | $4.88B | 3.11% |
| 2025-03-31 | $4.77B | 3.12% |
| 2024-12-31 | $4.67B | 2.64% |
| 2024-09-30 | $4.20B | 2.40% |

**Comprehensive Analysis**
-------------------------

Huntington Ingalls Industries Inc has shown a strong cumulative return of 97.43% compared to 92.89% for the S&P 500 index. The company's Alpha, Beta analysis indicates a relatively stable performance with some fluctuations in Alpha and Beta values. The recent stock price fluctuations show a slight increase with a 5-day SMA of $398.15 and a 60-day SMA of $326.27. The RSI and PPO index indicators indicate a neutral to slightly bullish market condition. The recent news and events suggest a positive outlook for the company. The analyst opinions are generally positive with a mean rating of 2.45, indicating a buy recommendation. The recent earnings analysis shows a decline in EPS and revenue in the last quarter. The financial information indicates an increase in revenue and equity in the last quarter but a decline in profit margin and ROE.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.